Institut National de la Sante et de la Recherche Medicale (INSERM) ;Centre National de la Recherche Scientifique (CNRS) ;Universite De Poitiers ;Sorbonne Universite ;Universite Claude Bernard Lyon 1
The present invention relates to a compound of the following general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as inhibitor of cellular necroptosis. The present invention also relates to a pharmaceutical composition comprising a compound of general formula (I), or a pharmaceutically acceptable salt and/or solvate thereof, for use for preventing and/or treating disorders associated with cellular necroptosis. The present invention also encompasses the use of a compound of the general formula (I) for organs preservation.;
